Lei Wang

机构：Jiangnan University, China Pharmaceutical University, University of Chicago, Hebei University of Chinese Medicine, First Affiliated Hospital of Harbin Medical University, Sichuan University of Science and Engineering, Xiamen University of Technology, Nanjing Medical University · ORCID：0000-0002-3024-8627

发表论文 138 篇 · 总被引 6736 次 · h-index 34

代表论文

• Improved green and red GRAB sensors for monitoring dopaminergic activity in vivo (2023 · Nature Methods · 被引 154)
• Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy (2022 · Frontiers in Cardiovascular Medicine · 被引 116)
• Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2 (2022 · Nature Communications · 被引 87)
• Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson’s Disease Mice Via Regulating Neuronal Apoptosis and Neuroinflammation (2022 · Neuroscience · 被引 43)
• Quercetin reverses 5-fluorouracil resistance in colon cancer cells by modulating the NRF2/HO-1 pathway (2023 · European Journal of Histochemistry · 被引 29)
• Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary (2022 · Journal of Cancer Research and Clinical Oncology · 被引 21)